The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma is a leading cause of cancer death worldwide. Due to the frequently late diagnosis, early metastasis and high therapy resistance curation is rare and prognosis remains poor overall. To provide early diagnostic and therapeutic predictors, various molec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturm, Niklas, Ettrich, Thomas J., Perkhofer, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750069/
https://www.ncbi.nlm.nih.gov/pubmed/35008381
http://dx.doi.org/10.3390/cancers14010217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750069/
https://www.ncbi.nlm.nih.gov/pubmed/35008381
http://dx.doi.org/10.3390/cancers14010217

Ejemplares similares